Alcohol, Smoking, Drugs: Can Digital Solutions Give A Helping Hand To The Addicted?

Alcohol content measuring wristbands, smart lighters, nicotine tracking wearables, stop smoking apps, virtual reality therapies, automated messaging platforms are the newest elements in the arsenal of digital health technologies supporting everyone in the fight against addiction to cigarettes, alcohol or drugs. Addiction and dependency ruins lives Once you become addicted, it sticks with you for a long time, if not for life. It doesn’t matter whether it’s about cigarettes, alcohol, medication, drugs, gambling, sex, etc., any of these substances or phenomena could cause you strong dependency and might impact your everyday life negatively. Just as in the case of chronic diseases, you will wake up and go to bed with it every single day. You may overcome the lowest points, but even if you manage to battle the substance – and yourself, for that matter –, the skeletal ruins of addiction will wait in a shadowy corner to retake shape due to a breakdown induced by psychological or environmental factors. As a worst case scenario, addiction eats up your life, your family’s lives – and in huge numbers even entire communities. The global statistics are disquieting. A study found that in 2015, the estimated prevalence of heavy episodic alcohol use was 18.4 percent in the adult population; 15.2 percent in the case of daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35 percent for past-year cannabis, amphetamine, opioid, and cocaine use, respectively. Euro...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Future of Medicine Future of Pharma Medical Professionals Patients Researchers alcohol cigarette digital health drugs health technology Innovation medication opioid opioid crisis smartphone smartphone apps smoking virtual Source Type: blogs

Related Links:

Authors: Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T Abstract COVID-19 is the pandemic that hit the world starting December 2019. Recent studies and international statistics have shown an increased prevalence, morbidity as well as mortality of this disease in male patients compared to female patients. The aim of this brief communication is to describe the pathophysiology of this sex-discrepancy, based on the infectivity mechanism of the coronavirus including the Angiotensin-Converting Enzyme 2 (ACE2), the Type II transmembrane Serine Protease (TMPRSS2), and the androgen receptor. This could help und...
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
Authors: Sánchez-Pérez P, González-Calero P, Poma-Saavedra FH, Orero-Calvé E, Devesa-Such R, Soldevila-Orient A, Henningsmeyer-Utrera B, Lacueva-Moya J Abstract The experience of a tertiary hospital and four hemodialysis centers attached to it during the COVID-19 epidemic is described. The organization of care that has been carried out and the clinical course of the 16cases of COVID-19 in hemodialysis patients are summarized. The joint application of measures, including patient screening, the early investigation of possible cases, the isolation of confirmed, investigational or contact ca...
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
Desperate Indian families searching for remdesivir are paying excessive sums to black market dealers.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
AbstractBackgroundThe aim of the study was to determine factors predicting lymph node metastasis in patients with T1 or T2 colon cancer.MethodsA total of 906 patients with T1 or T2 colon cancer who underwent colon resection with regional lymphadenectomy in a tertiary hospital, from January 2008 to December 2013, were analyzed. The prognostic factors for LN metastasis and the risk factors for survival were analyzed.ResultsThere were 728 patients (80.4%) without lymph node metastasis (LN-negative group) and 178 patients (19.6%) with lymph node metastasis (LN-positive group). Tumor invasion depth (P
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research
ConclusionsThe addition of ICT before NCRT seemingly shows no survival benefit on patients with LARC, and might increase the toxicity.
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research
SummaryChemotherapy has always been the first therapeutic option for patients with advanced non-small cell lung cancer (NSCLC) with untreatable oncogenic mutations. However, chemotherapy has demonstrated limited success and is associated with severe side effects. This research aimed to investigate the antitumor efficacy and cytotoxic safety of the conjugate ZHER2:V2-pemetrexed, a novel targeted chemotherapeutic drug. In this context, human epidermal growth factor receptor 2 (HER2)  + A549 lung xenografts were treated using ZHER2:V2-pemetrexed, pemetrexed or physiological saline. Therapeutic efficacy was monit...
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
Conclusion Panitumumab (6  mg/kg iv q 2 weeks) with BKM120 60 mg given 5 out of 7 days per week was declared the RP2D. Toxicities including fatigue, rash and mucositis. There was little evidence of activity in this biomarker unselected cohort.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
This study provides new information on the cellular effects of 1,3,5-triazine nitrogen mustards with different peptide groups in DLD and Ht-29 human colon cancer cell lines. A novel series of 2,4,6-trisubstituted 1,3,5-triazine derivatives bearing 2-chloroethyl and oligopeptide moieties was designed and synthesized. The most cytotoxic derivative was triazine with an Ala-Ala-OMe substituent on the ring (compound7b). This compound induced time- and dose-dependent cytotoxicity in the DLD-1 and HT-29 colon cancer cell lines. The triazine derivative furthermore induced apoptosis through intracellular signaling pathway attenuati...
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
Fostemsavir (Rukobia) is indicated for heavily treatment-experienced patients living with multidrug-resistant HIV infection.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Addiction | Advertising | African Health | Alcoholism | Amphetamine | Belarus Health | Brazil Health | Cancer | Cancer & Oncology | Cardiology | Computers | Emergency Medicine | Environmental Health | Epidemics | Epidemiology | Finland Health | Heart | Heart Disease | Heart Transplant | HIV AIDS | Iceland Health | India Health | Information Technology | Ischemic Stroke | Marketing | Men | Methamphetamine | Mexico Health | Middle East Health | Nicotine | Norway Health | Overdose | Pharmaceuticals | Psychiatry | Psychology | Rehabilitation | Respiratory Medicine | Russia Health | Saudi Arabia Health | Smokers | Statistics | Stroke | Study | Substance Abuse | Substance Abuse Disorders | Washington University | Women